Minimally invasive access type related to outcomes of sutureless and rapid deployment valves.

Aortic valve replacement Rapid deployment valve Sutureless and Rapid Deployment Aortic Valve Replacement International Registry Sutureless valve The International Valvular Surgery Study Group

Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
01 11 2020
Historique:
received: 01 12 2019
revised: 01 04 2020
accepted: 03 04 2020
pubmed: 27 6 2020
medline: 22 6 2021
entrez: 27 6 2020
Statut: ppublish

Résumé

Minimally invasive surgical techniques with optimal outcomes are of paramount importance. Sutureless and rapid deployment aortic valves are increasingly implanted via minimally invasive approaches. We aimed to analyse the procedural outcomes of a full sternotomy (FS) compared with those of minimally invasive cardiac surgery (MICS) and further assess MICS, namely ministernotomy (MS) and anterior right thoracotomy (ART). We selected all isolated aortic valve replacements in the Sutureless and Rapid Deployment Aortic Valve Replacement International Registry (SURD-IR, n = 2257) and performed propensity score matching to compare aortic valve replacement through FS or MICS (n = 508/group) as well as through MS and ART accesses (n = 569/group). Postoperative mortality was 1.6% in FS and MICS patients who had a mean logistic EuroSCORE of 11%. Cross-clamp and cardiopulmonary bypass (CPB) times were shorter in the FS group than in the MICS group (mean difference 3.2 and 9.2 min; P < 0.001). Patients undergoing FS had a higher rate of acute kidney injury (5.6% vs 2.8%; P = 0.012). Direct comparison of MS and ART revealed longer mean cross-clamp and CPB times (12 and 16.7 min) in the ART group (P < 0.001). The postoperative outcome revealed a higher stroke rate (3.2% vs 1.2%; P = 0.043) as well as a longer postoperative intensive care unit [2 (1-3) vs 1 (1-3) days; P = 0.009] and hospital stay [11 (8-16) vs 8 (7-12) days; P < 0.001] in the MS group than in the ART group. According to this non-randomized international registry, FS resulted in a higher rate of acute kidney injury. The ART access showed a lower stroke rate than MS and a shorter hospital stay than all other accesses. All these findings may be related to underlying patient risk factors.

Identifiants

pubmed: 32588056
pii: 5862900
doi: 10.1093/ejcts/ezaa154
pmc: PMC7577292
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1063-1071

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.

Références

Eur J Cardiothorac Surg. 2017 Aug 1;52(2):281-287
pubmed: 28453629
J Thorac Cardiovasc Surg. 2018 Mar;155(3):926-936.e2
pubmed: 29061465
Eur J Cardiothorac Surg. 2016 Mar;49(3):978-86
pubmed: 26245628
Eur J Cardiothorac Surg. 2019 Mar 1;55(3):527-533
pubmed: 30137264
Ann Thorac Surg. 2015 Jan;99(1):17-25
pubmed: 25441065
Eur J Cardiothorac Surg. 2018 May 1;53(suppl_2):ii29-ii31
pubmed: 29370367
Eur J Cardiothorac Surg. 2018 Mar 1;53(3):552-559
pubmed: 29190355
J Thorac Cardiovasc Surg. 2009 Mar;137(3):670-679.e5
pubmed: 19258087
Ann Thorac Surg. 2018 Dec;106(6):1881-1889
pubmed: 30189193
Cardiovasc Eng Technol. 2017 Mar;8(1):17-29
pubmed: 27873180
Ann Thorac Surg. 2015 Sep;100(3):868-73
pubmed: 26095105
Ann Thorac Surg. 2014 Oct;98(4):1499-511
pubmed: 25064516
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
EuroIntervention. 2018 Mar 20;13(16):1902-1903
pubmed: 29175769
J Thorac Cardiovasc Surg. 2014 Jul;148(1):133-7
pubmed: 24035370
Interact Cardiovasc Thorac Surg. 2016 Jun;22(6):799-805
pubmed: 26976130
Interact Cardiovasc Thorac Surg. 2017 Nov 1;25(5):818-821
pubmed: 29049755
Innovations (Phila). 2018 May/Jun;13(3):177-183
pubmed: 29912142
Eur J Cardiothorac Surg. 2008 Apr;33(4):523-8
pubmed: 18313319
Ann Cardiothorac Surg. 2015 Mar;4(2):131-9
pubmed: 25870808
J Thorac Cardiovasc Surg. 2014 Dec;148(6):2838-43
pubmed: 24698558
Eur J Cardiothorac Surg. 2018 Oct 1;54(4):768-773
pubmed: 29617925
Eur J Cardiothorac Surg. 2019 Oct 1;56(4):793-799
pubmed: 30820549
N Engl J Med. 2019 May 2;380(18):1706-1715
pubmed: 30883053
Ann Cardiothorac Surg. 2015 Jan;4(1):3-14
pubmed: 25694971
Eur J Cardiothorac Surg. 2016 Oct;50(4):713-720
pubmed: 26935407
J Thorac Cardiovasc Surg. 2020 Feb 19;:
pubmed: 32204909

Auteurs

Martin Andreas (M)

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Paolo Berretta (P)

Cardiac Surgery Unit, Lancisi Cardiovascular Center, Polytechnic University of Marche, Ospedali Riuniti, Ancona, Italy.

Marco Solinas (M)

Pasquinucci Heart Hospital, Massa, Italy.

Giuseppe Santarpino (G)

Città di Lecce Hospital, GVM Care & Research, Cotignola, Italy.
Cardiovascular Center, Paracelsus Medical University, Nuremberg, Germany.

Utz Kappert (U)

Department of Cardiac Surgery, University Heart Centre Dresden, Dresden, Germany.

Antonio Fiore (A)

Department of Cardiac Surgery, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France.

Mattia Glauber (M)

Istituto Clinico Sant'Ambrogio, Clinical & Research Hospitals IRCCS Gruppo San Donato, Milan, Italy.

Martin Misfeld (M)

University Clinic for Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.
Department of Cardiothoracic Surgery, The Royal Prince Alfred Hospital, Sydney, Australia.

Carlo Savini (C)

Cardiac Surgery Department, Sant'Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.

Elisa Mikus (E)

Cardiovascular Surgery Unit, Maria Cecilia Hospital GVM Care & Research, Cotignola, Italy.

Emmanuel Villa (E)

Cardiac Surgery Unit, Poliambulanza Foundation Hospital, Brescia, Italy.

Kevin Phan (K)

The Collaborative Research (CORE) Group, Sydney, Australia.

Theodor Fischlein (T)

Cardiovascular Center, Paracelsus Medical University, Nuremberg, Germany.

Bart Meuris (B)

Cardiac Surgery, Gasthuisberg, Cardiale Heelkunde, Leuven, Belgium.

Gianluca Martinelli (G)

Cardiovascular Department, Clinica San Gaudenzio, Novara, Italy.

Kevin Teoh (K)

Southlake Regional Health Centre, Newmarket, ON, Canada.

Carmelo Mignosa (C)

Department for the Treatment and Study of Cardiothoracic Diseases, Cardiothoracic Transplantation IRCCS-ISMETT, Palermo, Italy.

Malakh Shrestha (M)

Division of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.

Thierry P Carrel (TP)

Department of Cardiovascular Surgery, University Hospital, University of Bern, Bern, Switzerland.

Tristan Yan (T)

Department of Cardiothoracic Surgery, The Royal Prince Alfred Hospital, Sydney, Australia.
The Collaborative Research (CORE) Group, Sydney, Australia.

Guenther Laufer (G)

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Marco Di Eusanio (M)

Cardiac Surgery Unit, Lancisi Cardiovascular Center, Polytechnic University of Marche, Ospedali Riuniti, Ancona, Italy.
The Collaborative Research (CORE) Group, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH